At the time of the attack, the treatment consists of an injection of benralizumab, in a high dose. As reported by the media ...

Patients began with mepolizumab or benralizumab before switching to continuing with benralizumab at week 52. About 44% of patients stopped using oral glucocorticoids. Blood eosinophil counts fell ...

Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if used to treat acute asthma attacks, calling it the first major advance for this aspect of the disease in 50 ...

The same biological mechanism also underlies a third of all ... with asthma attacks almost every day. But the benralizumab injection he had in hospital helped stabilise his disease.